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Effects of cyclosporine in osteopontin null mice. tive indicator of tubulointerstitial inflammation and is
Background. Osteopontin (OPN) is a macrophage adhesive up-regulated in both experimental [2–5] and human [6–8]
and cell survival factor that is up-regulated in tubules in tubulo- tubulointerstitial injury. OPN is multifunctional and isinterstitial disease. We have previously reported that rats with
involved in macrophage recruitment, cell survival, regu-cyclosporine (CsA) nephropathy have increased tubular osteo-
lation of inducible nitric oxide synthase activity and inhi-pontin that correlates with the infiltration of macrophages and
interstitial fibrosis. This study tested the hypothesis that the bition of renal stone formation [9–14].
absence of OPN would ameliorate CsA nephropathy. Cyclosporine (CsA) nephropathy is a common com-
Methods. OPN knockout (/) and wild type (/) mice plication in transplantation [15]. CsA nephropathy alsowere fed a low salt diet (Na 0.01%) for one week and then
has been generated in rodents and has similar featuresreceived daily CsA injections (30 mg/kg, SC) until sacrifice at
to human disease, including afferent arteriolar hyalino-two weeks. Afferent arteriolopathy, tubulointerstitial injury,
macrophage infiltration, collagen III deposition, transforming sis and striped tubulointerstitial fibrosis [16–18]. Pichler
growth factor- (TGF-) expression, and tubular and intersti- et al reported that OPN expression was increased in CsA
tial cell proliferation and apoptosis were evaluated.
nephropathy in rats [17]. Furthermore, in individual ratsResults. Wild type mice developed early features of CsA
there was a strong correlation between the degree ofnephropathy, with arteriolar hyalinosis and cortical and tubulo-
OPN expression and the severity of the macrophageinterstitial fibrosis. Despite comparable CsA levels, OPN/
mice had less arteriolopathy (15 vs. 24%, P  0.05), a 20% infiltration and fibrosis [17]. This led to the hypothe-
reduction in cortical macrophage infiltration (P  0.05), and sis that OPN might be an important mediator of CsA
20% reduction in interstitial collagen deposition (P  0.05).
nephropathy.OPN/ mice also showed less cortical interstitial cell pro-
Recently the OPN knockout (OPN/) mouse hasliferation but no differences in tubular cell proliferation or
been generated, and the phenotype is associated with aapoptosis. OPN/ mice also developed some neurotoxicity,
consisting of ataxia, and this was associated with increased mild defect in wound healing [19]. Importantly, the kid-
mortality at two weeks. neys of OPN/ mice are normal. This observation,
Conclusion. OPN partially mediates arteriolopathy, early coupled with the recent development of a model of CsAmacrophage recruitment and fibrosis in murine CsA nephropa-
nephropathy in mice [20], allowed us to directly addressthy. OPN also may be involved in CsA associated neurotoxicity.
whether OPN has a functional role in CsA nephropathy.
Osteopontin (OPN) is an Arg-Gly-Asp (RGD-con- METHODS
taining) adhesive glycoprotein and is expressed at low
Experimental animalslevels by proximal and distal tubular epithelial cells in
Deletion of the OPN gene was performed by targetednormal kidney tissue [1]. However, OPN is a very sensi-
disruption as described previously [19]. Homozygous
null mutant mice (/) were viable and fertile, and
1 See Editorial by Hoyer, p. 348. breeding pairs of a (129/SvJx Black Swiss) hybrid genetic
background were established to generate the animalsKey words: osteopontin, cyclosporine, macrophages, tubulointerstitial
injury. used in the present study. Wild-type breeding pairs of
the same genetic background (129/SvJ Black Swiss) wereReceived for publication August 15, 2001
used as controls. The genotype of animals was confirmedand in revised form February 12, 2002
Accepted for publication February 14, 2002 by polymerase chain reaction (PCR) analysis. Previous
studies indicated that osteopontin null mutant mice ex- 2002 by the International Society of Nephrology
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hibited normal kidney architecture and renal function, Detection of proximal and distal tubular cell
proliferation and apoptosisunless exposed to overt renal injury [11, 21].
Prior to immunostaining for BrDU, tissue sections
Study design underwent an antigen retrieval step comprising of boiling
in 0.01 mol/L sodium citrate buffer for a total of 10Seventeen mice [7 knockout (/) and 10 wild type
minutes. Sections were then incubated with a murine(/)], 20 to 24 weeks old, were housed in individual
IgG2a monoclonal antibody against BrdU (Cell prolifer-cages in an air, temperature and light controlled environ-
ation kit; Amersham) at room temperature for 60 min-ment and received a low salt diet (0.01% Na; (Zeigler
utes, followed by a peroxidase conjugated goat anti-Bros, Gardners, PA, USA) and water ad libitum. After
mouse IgG2a (Cell proliferation kit; Amersham) at roomone week on low salt diet, daily subcutaneous injections
temperature for 30 minutes. A black color was developedof CsA (Novartis) were administered at a dose of 30
using DAB with nickel chloride as the chromogen.mg/kg diluted in olive oil for two weeks. These doses of
Apoptotic cells were detected by the TUNEL assayCsA and the use of a low salt diet have been found to
as previously described [23]. Briefly, 4 m formalin-fixed
be necessary for the induction of CsA nephropathy in tissue sections were deparaffinized and rehydrated in
mice [20]. At day 13 mice were housed in individual ethanol followed by an antigen retrieval step comprising
metabolic cages for 24-hour urine collection. On the of boiling in 0.01 mol/L sodium citrate buffer for two
following day, mice received IP injections of BrDU label- minutes. Sections were incubated with proteinase K (6.2
ing solution (1 mL/100 g body wt; Cell Proliferation kit; g/mL; Boehringer Mannheim, Mannheim, Germany),
Amersham Pharmacia Biotech, Bucks, UK) and were followed by TdT (300 enzyme U/mL; Pharmacia Biotech,
sacrificed after two hours. Renal biopsies were obtained Piscataway, NJ, USA) and Bio-14-dATP (0.94 nmol/L;
from each animal. Control tissue was obtained from un- Gibco BRL, Grand Island, NY, USA). Biotinylated ATP
treated OPN/ (N  6) and OPN/ (N  5) mice was detected using the ABC staining method (Vector
for comparison. The studies were approved by the Uni- Laboratories Inc.) following the manufacturer’s proto-
col. As a positive control, slides were pretreated withversity of Washington Animal Care Committee.
DNAase (20 Kunitz U/mL; Sigma Biosciences). Cells
were considered TUNEL positive if their nuclei stainedFunctional data
black and displayed a typical apoptotic morphology withSerum blood urea nitrogen (BUN) was determined
chromatin condensation.colorimetrically using a standard kit (Sigma, St Louis,
In order to identify and accurately quantify proximalMO, USA). Cyclosporine levels were measured by high
versus distal tubular epithelial cell proliferation and apo-
performance liquid chromatography in whole blood. ptosis, Fx1A/BrdU and Fx1A/TUNEL double labeling
was performed. The Fx1A antibody was raised against
Renal histology rat proximal tubular brush border antigen as described
Renal biopsies were fixed in either Methyl-Carnoy’s previously and specifically stains the brush border of
or 10% buffered formalin and embedded in paraffin. proximal tubular epithelial cells [24]. Sections were in-
Light microscopy was performed in 4 m sections of cubated with biotinylated sheep Fx1A antibody at 4C
overnight, followed by horseradish peroxidase conju-Methyl-Carnoy’s fixed tissue stained with periodic acid-
gated avidin D (Vector Laboratories) for 20 minutes atSchiff (PAS) reagent. Methyl-Carnoy’s fixed tissue sec-
room temperature. Staining was developed using DABtions were analyzed by indirect immunoperoxidase stain-
without nickel to produce a brown color. BrdU oring with the following primary antibodies: OP199, a goat
TUNEL staining was then performed as indicated pre-polyclonal antibody against osteopontin (OPN) [22];
viously using DAB with nickel as the chromogen.F4/80 a rat monoclonal antibody to mouse macrophages
(Caltag, Burlingame, CA, USA); goat antihuman type III In situ hybridization for TGF-1
collagen (Southern Biotechnology Associates Inc, Bir-
A previously characterized pGEM T7 plasmid (Pro-mingham, AL, USA). Sections were incubated with a
mega, Madison, WI, USA) containing a 974 kb (421
secondary antibody followed by horseradish peroxidase- to 1395 bp) of mouse transforming growth factor-1
conjugated avidin D (Vector Laboratories, Burlingame, (TGF-1) cDNA was provided by Dr. H.L. Moses (Van-
CA, USA), diaminobenzidine (DAB; Sigma) with or derbilt University, Nashville, TN, USA) [25, 15]. The
without nickel chloride as a chromogen, and counter- plasmid was linearized with HindIII and Eco RI and
stained with methyl green. An irrelevant primary anti- transcribed into antisense and sense (negative control)
body of the same isotype was used as a negative control. riboprobes in T7- and SP6-primed reactions, using re-
Positive control tissue included sections from diseased agents from Promega, except 35S-UTP, obtained from
New England Nuclear (Boston, MA, USA).mice that expressed these antigens.
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Formalin fixed, paraffin embedded tissues were depar- Macrophage infiltration
affinized following standard protocols. In situ hybridiza- Macrophage infiltration was measured by determining
tion followed methods previously described [26]. The the amount of cortical and medullary tissue stained for
sections were washed with 0.5 standard sodium citrate F4/80 (over background), using computer assisted image
(SSC; Gibco) and digested with 5 g/mL of proteinase K analysis at 200 magnification.
(Sigma) in Tris buffer (500 mmol/L NaCl, 10 mmol/L Type III collagen deposition. Type II collagen deposits
Tris, pH 8.0) for 30 minutes at 37C. Several 0.5  SSC were measured by computer image analysis, at 50
washes were followed by prehybridization for two hours magnification, and expressed as the percentage of renal
in 50 L of prehybridization buffer [50% formamide, cortex or medulla occupied by type III collagen.
0.3 mmol/L NaCl, 20 mmol/L Tris pH 8.0, 5 mmol/L Tubular cell proliferation and apoptosis. These were
ethylenediaminetetraacetic acid (EDTA), 1  Den- measured by counting the number of Fx1A/BrDU,
hardt’s solution, 10% dextran sulfate, 10 mmol/L dithio- Fx1A/BrDU, Fx1A/TUNELand Fx1A/TUNEL
threitol (DTT), 500 g/mL yeast tRNA] at 50C. The cells in 20 sequentially selected 0.1 mm2 grids, in the
hybridization was started by adding 500,000 cpm of renal cortex, at 200 magnification, and expressed as
35S-labeled riboprobe in 50 L of prehybridization buffer the number of cells per mm2.
and was allowed to proceed overnight at 50C. Sections Interstitial cell proliferation and apoptosis. Interstitial
were then washed with 2  SSC, followed by RNAse A cell proliferation and apoptosis were measured by count-
(20 g/mL, 30 min at room temperature), 2  SSC ing the number of BrDU and TUNEL positive cells in
washes (3  1 min), three high-stringency washes with 20 sequentially selected 0.1 mm2 grids in the renal cortex
0.1  SSC/0.1% Tween 20 (Sigma) at 50C and three and 10 in the renal medulla, at 200 magnification, and
2 washes. The slides were dipped in NTB2 nuclear expressed as the number of cells per mm2.
emulsion (Kodak, Rochester, NY, USA) and exposed In situ hybridization. Positive cellular labeling was de-
in the dark at 4C for four weeks. After developing, fined as five or more silver grains in a single cell. For
sections were counterstained with hematoxylin and eosin negative controls, simultaneous hybridization with the
and were dehydrated and coverslipped. Positive cellular sense riboprobe was performed on replicate tissue.
labeling was defined as five or more silver grains in a
Statistical analysissingle cell. For negative controls, simultaneous hybrid-
ization with the sense riboprobe was performed on repli- All values are expressed as mean 	 SD, unless other-
cate tissue sections. wise stated. Statistical significance (P  0.05) was evalu-
ated by ANOVA, with appropriate correction for multi-
Quantification of morphologic data ple comparisons (Fisher PSLD).
All quantification was performed with the examiner
blinded to its origin.
RESULTSCortical tubulointerstitial injury and fibrosis. This was
Survival was lower in OPN / mice treatedscored semiquantitatively by analyzing cortical tubuloin-
with CsAterstitial fields on PAS stained tissue sections, and grad-
ing the degree of tubular changes (atrophy/dilation) and The mortality of mice treated with CsA was signifi-
interstitial expansion using a score from 0 to 5, as pre- cantly reduced in the OPN/ mice compared to
viously described [17]. OPN/ mice at two weeks (0% vs. 50%, P  0.05).
Arteriolar hyalinosis. Arteriolar hyalinosis of the af- Two of five of the OPN/ mice that died developed
ferent arteriole was quantified by counting the number ataxia 24 to 48 hours prior to death, whereas this was
of juxtaglomerular afferent arterioles which exhibited not observed in other OPN/ or OPN/ mice. We
hyalinosis, characterized by the presence of hyaline ma- cannot exclude that the etiology of the mortality was
terial in the cross sectional vascular area, and was ex- related to worse kidney disease or CsA-induced neuro-
pressed as a percentage of the total number of juxtaglom- toxicity, since histologic analyses and BUN and CsA
erular afferent arterioles present in the biopsy under levels were not able to be performed in the mice that
examination with the 40 objective [17]. died. However, in the survivors, both serum BUN and
Tubular expression of osteopontin. This was calcu- CsA blood levels were comparable (Table 1). Food in-
lated as the percent of renal cortex occupied by OPN- take was also similar in both groups although OPN/
positive tubules. Utilizing computer-assisted image anal- mice showed greater weight loss (mean weight loss at 1
ysis software (Optimas V6.2; Media Cybernetics, Silver week 4 g/week,
10% baseline body weight; Table 1).
Springs, MD, USA) and digitized images, the percent of
OPN is up-regulated in murine CsA nephropathyarea occupied by OPN positive tubules per 4 mm2 field
at a magnification of 50 was measured and the mean Osteopontin was up-regulated in tubules of renal cor-
tex of OPN/ mice after two weeks of CsA treatmentpercent area calculated for each biopsy.
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Table 1. Cyclosporine levels, body weight and renal function type (Fig. 2 A, B). Interestingly, the interstitial cell prolif-
after two weeks of cyclosporine treatment
eration correlated directly with the degree of macro-
OPN/ OPN/ phage infiltration when both groups were combined (r 2
Number of animals 7 5 0.72, P  0.05; Fig. 2 C, D).
CsA ng/dL 3332.0	230.8 3247.5	496.8 Osteopontin has been reported to be a cell survival
BUN baseline mg/dL 30.3	1.8 23.4	2.2
factor, and OPN/ mice show increased apoptosis inBUN 2 weeks mg/dL 80.9	15.6 66.7	16.6
BW baseline g 38.2	1.6 40.7	0.9 the obstructive uropathy model [10]. However, no differ-
BW 1 week g 37.8	1.4 36.6	5.9a ences were evident between genotypes in the number of
BW 2 weeks g 35.2	0.7 39.1	0.9
TUNEL positive apoptotic cells in the cortex or theHct baseline % 45.3	1.5 44.9	1.0
Hct 2 weeks % 43.3	1.6 42.3	1.0 medulla (Table 2).
Abbreviations are: CsA, cyclosporine levels; OPN, osteopontin; BUN, blood
urea nitrogen; BW, body weight; Hct, hematocrit. OPN/ mice exhibited comparable TGF-1
a P  0.05 vs. baseline body weight mRNA expression
Transforming growth factor-1 mRNA expression
was detected in rare scattered intra-glomerular cells and
arterial endothelial cells of control kidney tissue from(1.9 	 0.6% vs. 0.6 	 0.3% cortical area, CsA 2 weeks
both untreated OPN/ and OPN / mice. In CsA-vs. untreated, N  5 per group, P  0.05; Fig. 1 A, B).
treated mice TGF-1 mRNA was expressed in both tu-OPN/mice also showed up-regulation of OPN in the
bular and interstitial cells in scattered foci, usually butmedulla compared to untreated OPN/ mice (1.9 	
not exclusively in regions with an interstitial inflam-0.3 vs. 0.5 	 0.2% medullary area, P  0.05, N  5 per
matory infiltrate. No distinct alterations in patterns ofgroup). No expression of osteopontin was detected in
TGF-1 mRNA expression were identified in CsA-either untreated or CsA treated OPN/ mice.
treated OPN/ versus OPN/mice at the two-week
Murine CsA nephropathy is attenuated in time point.
OPN/ mice
After two weeks of CsA injections, both OPN/ DISCUSSION
and OPN/ mice developed arteriolopathy and tubu- Recent studies suggest that OPN may have a role
lointerstitial injury consistent with early CsA nephrotox- as a macrophage adhesive factor in renal disease. OPN
icity (Fig. 1C). OPN/ mice, however, displayed sig- binds macrophages with high affinity [27] and OPN will
nificantly fewer lesions of arteriolar hyalinosis compared elicit a macrophage-rich infiltration on injection into
to the OPN/ mice (15 vs. 24%, P  0.05; Table 2). mice, rats or rabbits [27, 28]. In the kidney, OPN is ex-
Interestingly, de novo expression of OPN was found pressed constitutively by distal tubules in the juxta-
in the preglomerular arterial vessels in OPN/ mice medullary cortex and outer medulla [1]. However, OPN
treated with CsA (Fig. 1D). is induced in proximal and distal tubules in both immune
While there was no difference in tubulointerstitial in- and nonimmune models of tubulointerstitial injury [3–5,
jury scores, there was significant although mild reduction 29, 30]. In these models the up-regulation of OPN corre-
in both cortical macrophage (F4/80) infiltration and corti- lates both spatially and quantitatively with the infiltra-
cal type III collagen deposition in the OPN/ mice tion of macrophages and with the development of fibrosis
(Table 2). These changes were present despite similar [3, 10, 17, 31].
blood levels of CsA (Table 1). Pichler et al have reported that OPN is up-regulated
In contrast to the difference in cortical injury, there in CsA nephropathy in rats, and that this was associated
was no difference in macrophage infiltration or type III with increased macrophage infiltration and fibrosis [17].
collagen deposition in the medulla between genotypes. Thomas et al have also reported that CsA nephropathy
is associated with tubular cell apoptosis, and this also
Role of osteopontin in renal cell proliferation correlates with the degree of fibrosis [32]. We therefore
and apoptosis decided to examine the functional role of OPN in a
Cyclosporine A nephropathy in OPN/ and OPN/ murine model of CsA nephropathy.
mice was associated with both tubular and interstitial The role of OPN in macrophage attraction and pro-
cell proliferation, as determined by BrdU incorporation. liferation has been investigated using several different
There was no difference in proximal (FX1A) or distal techniques. In the anti-glomerular basement membrane
(FX1A) tubular cell proliferation between genotypes (anti-GBM) model, inhibition of OPN with antibody or
(Table 2). However, the number of proliferating BrdU- antisense therapy results in a reduction in macrophage in-
positive interstitial cells in the renal cortex was signifi- filtration and fibrosis [31, 33]. In the unilateral ureteral
obstruction (UUO) model, OPN has been shown to me-cantly reduced in OPN/ mice compared to the wild
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Fig. 1. Osteopontin (OPN) was up-regulated
in cyclosporine (CsA) nephropathy in
OPN/ mice and was expressed in preglo-
merular arterial vessels. Tubular expression
of OPN was increased in both cortical and
medullary areas in OPN/mice treated with
CsA for 2 weeks (B) compared to untreated
OPN/ mice (A). The histological findings
of CsA nephropathy (tubular atrophy and di-
latation, striped fibrosis and afferent arteriolar
hyalinosis (C ) was similar in both OPN/
and OPN/mice. However, OPN/mice
showed increased incidence of afferent arteri-
olar hyalinosis and expression of OPN in affer-
ent arterioles (arrow) (D). (A and B, immuno-
histochemistry for osteopontin, magnification
50; C, PAS staining, 50; D, osteopontin
staining, 1000).
Table 2. Histological data in control and CsA treated mice
Control 2 weeks of CsA
OPN/ OPN/ OPN/ OPN/
N 6 5 7 5
TI injury score (PAS) 0.20	0.12 0.26	0.18 0.76	0.43 0.56	0.23
Arteriolar hyalinosis % 0 0 14.9	7.0a 23.8	4.6
Type III collagen cortex
% area 1.93	1.42 2.14	1.64 8.74	2.2a 10.45	3.1
F4/80 cortex % area 0.10	0.11 0.23	0.21 0.81	0.13a 1.02	0.09
IC proliferationb
BRDU cells/mm2 3.90	1.52 5.64	1.92 20.1	3.9a 32.0	1.7
IC apoptosis
TUNEL cells/mm2 0.33	0.30 0.24	0.20 4.48	0.64 5.44	0.74
PTC proliferationb
BRDU/FX1A cells/mm2 0.64	0.70 0.35	0.49 3.14	1.0 4.3	1.5
PTC apoptosis
TUNEL/FX1A cells/mm2 0.11	0.10 0.05	0.09 2.13	0.8 1.56	0.41
DTC proliferationb
BRDU/FX1A cells/mm2 0.03	0.07 0.04	0.08 1.0	0.3 0.8	0.11
DTC apoptosis
TUNEL/FX1A cells/mm2 0 0.05	0.08 0.11	0.05 0.20	0.12
Medulla
Type III collagen % area 5.54	4.92 5.84	2.42 22.4	4.3 23.8	5.2
Macrophage infiltration
% area 0.36	0.29 0.29	0.15 11.8	2.3 11.8	2.3
Medullary cell proliferationb
BRDU cells/mm2 1.06	0.38 1.16	0.40 11.8	2.3 18.4	0.8
Medullary cell apoptosis
TUNEL cells/m2 0.23	0.21 0.68	0.24 1.11	0.16 2.80	1.50
Abbreviations are in Table 1 and: IC, interstitial cell; PTC, proximal tubular cell; DTC, distal tubular cell.
a P  0.05 vs. OPN/ mice at the same time point
b Proliferation studies with Brdu were performed on only a subset of mice (5 control OPN/, 5 OPN/, and 4 each of CsA-treated OPN/ and / mice)
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Fig. 2. The lack of OPN was associated with less interstitial cell proliferation and macrophage infiltration. The number of proliferating BrdU
positive cells (arrows) in interstitial renal cortex (arrows) was reduced in OPN/ mice (A) compared to OPN/ (B). The interstitial cell
proliferation correlated directly with the degree of macrophage infiltration (C and D). A and B, double staining FX1A/BrdU, 640 (BrdU cells
stained in black, proximal tubular brush border stained in brown); C shows macrophage infiltration, F4/80 staining, 200). Symbols in D are: ()
OPN/ control; () OPN/ control; () OPN/ 2 weeks; () OPN/ 2 weeks.
diate the early macrophage infiltration and fibrosis, as OPN knockout mouse. It is also possible that the
OPN/mice that died may have had worse nephrotox-evidenced by studies using knockout mice [11]. It is im-
portant to realize, however, that blocking OPN only had icity. Nevertheless, our data are consistent with previous
studies that suggest that the role for OPN in macrophagea partial effect on macrophage infiltration in these mod-
els, thereby suggesting the importance of other chemo- recruitment is relatively minor [11, 31, 34].
The second interesting finding was that the OPN wastactic (such as, chemokines) [34] and adhesive factors
(such as, ICAM-1) [35] on the renal inflammatory expressed de novo in the preglomerular arterial vessels
of CsA-treated OPN/ mice, and that OPN/ miceresponse.
Our primary finding was that OPN mediated the early showed less arteriolar hyalinosis compared to the
OPN/mice. The afferent arteriolar hyalinosis in CsAmacrophage infiltration and type III collagen deposition
in the cortex in the CsA nephropathy model. The reduc- nephropathy involves endothelial and smooth muscle
injury resulting in the subendothelial accumulation oftion in macrophage infiltration and fibrosis in the
OPN/ mice were mild (20%), and as such, this did proteinaceous material, and this has been previously
shown to be mediated by angiotensin II [16, 17] and tonot result in any differences in renal function. It is possi-
ble that the mild differences in macrophage accumula- be ameliorated by vascular endothelial growth factor
(VEGF) infusion [36]. Interestingly, OPN has beention in OPN/ and OPN/mice may reflect compen-
satory mechanisms for macrophage recruitment in the shown to be produced by injured vascular smooth muscle
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cells in a variety of conditions [37–40]. In vascular dis- In conclusion, OPN appears to have a modest role
in macrophage recruitment and in the development ofease, OPN has been posited to mediate smooth muscle
cell adhesion and migration [41] as well as endothelial fibrosis in the murine CsA nephropathy model, which
is consistent with studies in other models [2, 11, 31].migration and survival [12]. Indeed, neointimal thick-
ening following coronary or carotid angioplasty can be Interestingly, OPN also may be involved in the induction
reduced by inhibiting OPN with antibody [42] or with of the arteriolopathy in CsA rats. This suggests that
antisense [43] therapy. Therefore, OPN may be partially OPN may have an additional role in mediating renal
responsible for the arteriolar injury that occurs in CsA microvascular injury, and is consistent with emerging
treated mice. roles for OPN in vascular disease [10, 50].
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